Drugs /

astx029

Back to Drugs List
Associated Genetic Biomarkers

Overview

Clinical Trials

View Clinical Trials for astx029

Astx029 has been investigated in 1 clinical trial, of which 1 is open and 0 are closed. Of the trial investigating astx029, 1 is phase 1/phase 2 (1 open).

Malignant solid tumor is the most common disease being investigated in astx029 clinical trials [2].

Drug Details

Synonyms [2]:
astx 029, astx-029, erk inhibitor astx029, erk 1/2 inhibitor astx029
Drug Categories [2]:
ERK inhibitor, Serine/threonine kinase inhibitors
Drug Target(s) [2]:
MAPK1, MAPK3
NCIT ID [1]:
C155785

References

1. National Cancer Institute. NCI Thesaurus Version 18.11d. https://ncit.nci.nih.gov/ncitbrowser/. [2018-07-30] [2018-08-02].

2. All assertions and clinical trial landscape data are curated from primary sources. You can read more about the curation process here.